(4-Methoxy-3-methylpyridin-2-yl)methanol, 95.0%, 1g

3-Amino-benzo[b]thiophene-2-carboxylic acid ethyl ester, 95.0%, 1g

Cephalosporinase from Bacillus (1000000unit/vial)1vial

6,8-Difluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride, 97%, 1g

3-Chloro-2-(3-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine, 95%, 1g

3-Chloromethyl-5-nitrosalicylaldehyde>97.0%(HPLC)(T)5g

2-Bromo-3-hydroxymethyl-thiophene, 95.0%, 250mg

Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate hydrochloride, 98%, 1g

(3aS,4R,6S,6aR)-6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-amine, 98%, 50mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)picolinaldehyde, 95.0%, 5g

1,4-Bis(2-propynyloxy)benzene, 98% GC, 1g

Colonne capillaire GC ROTI®Cap-XLB, 60 m, 1 Pièce(s)

(R)-3-(3-(Allyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g